The results suggest a possible trend of increased SCRT in more advanced stage III/IV, although not statistically significant ( P = 0.06; Fig. 4D ).
← all excerpts
E-selectin affinity glycoproteomics reveals neuroendocrine proteins and the secretin receptor as a poor-prognosis signature in colorectal cancer.
1
—
—